Pediatric Arthritis Study of Certolizumab Pegol

Clinical trial NCT01550003 · COMPLETED

Trial details

NCT number: NCT01550003
Sponsor: UCB BIOSCIENCES GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Polyarticular-course Juvenile Idiopathic Arthritis (JIA)

Start date: 2012-03-08
Primary completion: 2024-04-08
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.